Coincidentally, EGCG enhances the inhibitory roles of 5-fluorouracil in hepatoma growth by eliminating 5-fluorouracil-induced COX-2 overexpression and PGE2 secretion (Yang et al., 2012). The gene discussed is PTGS2; the disease is hepatocellular carcinoma.